Latest filing published 29 Jun 2016 for Paratek Pharmaceuticals, Inc., €908k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Omega Fund III, L.P.: trading record in brief
Omega Fund III, L.P. discloses dealings in Paratek Pharmaceuticals, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 27 June 2016.
Purchases make up the whole of the open-market record (2 purchases, €5.4M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 29 June 2016 came the latest disclosure, an open-market purchase for €908k in Paratek Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Omega Fund III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 76,923 shares@ US$13.0016.7% of flowCommon StockSEC:0001209191-16-130106:0Canonical exit: 25 Sept 2016 (T+90)
- 384,615 shares@ US$13.0083.3% of flowCommon StockSEC:0001209191-16-130106:1Canonical exit: 25 Sept 2016 (T+90)
2 of 2 declarations
